Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

Cited by (270)

Items 201–270 of 270

1. Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus
   Zenglei Hu, Jiangyan Zhao, Lei Shi, Jiao Hu, Xiaoquan Wang, Xiufan Liu, Shunlin Hu, Min Gu, Xiufan Liu · 2021 · Virus Research
2. One HA stalk topping multiple heads as a novel influenza vaccine
   Ping Zhou, Tianyi Qiu, Xiang Wang, Xi Yang, Hongyang Shi, Caihong Zhu, Weiqian Dai, Man Xing, Xiaoyan Zhang, Jianqing Xu et al. · 2023 · Emerging Microbes & Infections
3. Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy – a balancing act
   Hillary A. Vanderven, Stephen John Kent · 2023 · Frontiers in Immunology
4. Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope
   Michael Bick, Eduard Puig, David Beauparlant, Rebecca Nedellec, Iszac Burton, Keihvan Ardaghi, Thea R. Zalunardo, Raiza B. Bastidas, Xuduo Li, Javier Guenaga et al. · 2025 · Cell Reports
5. Stereotyped B-cell response that counteracts antigenic variation of influenza viruses
   Keisuke Tonouchi, Yu Adachi, Saya Moriyama, Kaori Sano, Koshiro Tabata, Keigo Ide, Haruko Takeyama, Tadaki Suzuki, Yoshimasa Takahashi · 2020 · International Immunology
6. Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
   Boitumelo M. Motsoeneng, Nisha Dhar, Marta Coelho Nunes, Florian Krammer, Shabir Ahmed Madhi, Penny L. Moore, Simone I. Richardson · 2022 · Frontiers in Immunology
7. Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses
   Ayae Nishiyama, Yu Adachi, Keisuke Tonouchi, Saya Moriyama, Lin Sun, Masamitsu Aoki, Hideki Asanuma, Masayuki Shirakura, Akihisa Fukushima, Takuya Yamamoto et al. · 2023 · Vaccine
8. A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
   Mark J. Bailey, Felix Broecker, Paul E. Leon, Gene S. Tan · 2018 · Journal of Visualized Experiments
9. Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin
   Jessica F. Trost, Elizabeth H. LeMasters, Feng Liu, Paul J. Carney, Xiuhua Lu, Kanetsu Sugawara, Seiji Hongō, James Stevens, David A. Steinhauer, Terrence M. Tumpey et al. · 2018 · PLoS ONE
10. Development and biochemical characterization of the monoclonal antibodies for specific detection of the emerging H5N8 and H5Nx avian influenza virus hemagglutinins
    Yu‐Chen Cheng, Shih‐Chung Chang · 2020 · Applied Microbiology and Biotechnology
11. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 + T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway
    Sonia Jain, Parakkal Jovvian George, Wanyan Deng, Joseph Koussa, Kaela Parkhouse, Scott E. Hensley, Jiu Kun Jiang, Jie Li Lu, Zhuyun Liu, Junfei Wei et al. · 2018 · Vaccine
12. Single-cell sequencing of plasma cells from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing antibodies to SARS-CoV-2
    Roy A. Ehling, Cédric R. Weber, Derek M. Mason, Simon Friedensohn, Bastian Wagner, Florian Bieberich, Edo Kapetanovic, Rodrigo Vazquez-Lombardi, Raphaël B. Di Roberto, Kai-Lin Hong et al. · 2021 · bioRxiv
13. Mapping antibody footprints using binding profiles
    Asaf Azulay, Liel Cohen-Lavi, Lilach M. Friedman, Maureen Ann McGargill, Tomer Hertz · 2023 · Cell Reports Methods
14. Protective Non-neutralizing anti–N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
    Arman Izadi, Magdalena Godzwon, Anna Söderlund‐Strand, Tobias Schmidt, Susanna Kumlien Georén, Christian Drosten, Mats Ohlin, Pontus Nordenfelt · 2024 · The Journal of Immunology
15. Live Attenuated Influenza Vaccines for Pandemic Preparedness
    Kanta Subbarao · 2019 · Journal of the Pediatric Infectious Diseases Society
16. Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
    Robert V. House, Thomas A. Broge, Todd J. Suscovich, Doris M. Snow, Milan T. Tomic, Genevieve H. Nonet, Kamaljit Bajwa, Guangyu Zhu, Zachary Martinez, Kyal Hackett et al. · 2022 · PLoS ONE
17. Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses
    Peter Radvák, Martina Košíková, Charles Yuan-Chia Kuo, Xing Li, Richard Garner, Falko Schmeisser, Ivan Košík, Zhiping Ye, Jerry P. Weir, Jonathan Wilson Yewdell et al. · 2021 · npj Vaccines
18. Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design
    Jiale Zhang, Chuang Li, Yuanyuan Wu, Lili Wang, Jie Yu, Aofan Wang, Wenwen Kong, Mingzhe Ning, J M Chen, Yuxin Chen · 2026 · Frontiers in Immunology
19. Characterization of antibody‐dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes
    Anurag Adhikari, Arunasingam Abayasingam, Nicholas A. Brasher, Ha Na Kim, Megan Susan Lord, David Agapiou, Lisa Maher, Chaturaka Rodrigo, Andrew R. Lloyd, Rowena Anne Bull et al. · 2024 · Journal of Medical Virology
20. Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression
    Marloes Grobben, Margreet E. Bakker, Angela I. Schriek, Liesbeth J.J. Levels, Jeffrey C. Umotoy, Khadija Tejjani, Mariëlle J. van Breemen, Ryan N. Lin, Steven W. de Taeye, Gabriel Ozorowski et al. · 2024 · PLoS Pathogens
21. Self-assembly polymerization enhances the immunogenicity of influenza M2e peptide
    Peng Zou, Yuan Li, Jinghe Huang, Fan Wu · 2017 · Microbes and Infection
22. Isolation of an in Vitro Affinity-Matured, Thermostable “Headless” HA Stem Fragment That Binds Broadly Neutralizing Antibodies with High Affinity
    Tariq Ahmad Najar, Uddipan Kar, Jessica A. Flynn, Raghavan Varadarajan · 2018 · Biochemistry
23. Exploring the global immune landscape of peripheral blood mononuclear cells in H5N6-infected patient with single-cell transcriptomics
    Jiamin Gao, Jing Wei, Simei Qin, Sheng Liu, Shuangyan Mo, Long Qian, Shiji Tan, Ning Lu, Zhouhua Xie, Jianyan Lin · 2023 · BMC Medical Genomics
24. Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017
    Cong Chen, Zuliang Liu, Liguo Liu, Yan Xiao, Jianmin Wang, Qi Jin · 2018 · Emerging Microbes & Infections
25. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014–15
    Kelsey R. Florek, James P. Mutschler, Huong Q. McLean, Jennifer P. King, Brendan L. Flannery, Edward A. Belongia, Thomas C. Friedrich · 2019 · Vaccine
26. A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin
    Jenna J. Guthmiller, Julianna Han, Henry A. Utset, Lei Li, Linda Yu-Ling Lan, Carole Henry, Christopher T. Stamper, Olivia Stovicek, Lauren E. Gentles, Haley L. Dugan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
27. A single-dose intranasal immunization with a novel bat influenza A virus-vectored MERS vaccine provides effective protection against lethal MERS-CoV challenge
    Lei Shi, Sawrab Roy, Yuekun Lang, Yuhan Wen, William J. Mitchell, Wenyu Yang, Liping Wang, Jialin Zhang, Heidi Liu, John P. Driver et al. · 2025 · mBio
28. Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination
    Ayae Nishiyama, Takuto Nogimori, Yuji Masuta, Tomoka Matsuura, Tetsuo Kase, Kyoko Kondo, Satoko Ohfuji, Yu Nakagama, Natsuko Kaku, Sachie Nakagama et al. · 2025 · Vaccines
29. Global Prevalence and Hemagglutinin Evolution of H7N9 Avian Influenza Viruses from 2013 to 2022
    Qianshuo Liu, Haowen Zeng, Xinghui Wu, Xuelian Yang, Guiqin Wang · 2023 · Viruses
30. Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model
    Zhao-Yong Zhang, Lu Zhang, Ai-Ru Zhu, Yan-Qun Wang, Wen-Da Guan, Zhi-Qi Zeng, Jing Sun, Fang Li, Jing-Xian Zhao, Zi-Feng Yang et al. · 2020 · Journal of Thoracic Disease
31. Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection
    Daria V. Voronina, Банделюк Алина Сергеевна, Alina Sh. Dzharullaeva, Olga D. Popova, Vladislav Y. Kan, Ilias B. Esmagambetov, Irina A. Favorskaya, Dmitry V. Shcheblyakov, Boris Savelyevich Naroditskiy, Gintsburg Al · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
32. Antibodies elicited by Newcastle disease virus-vectored H7N9 avian influenza vaccine are functional in activating the complement system
    Zenglei Hu, Ya Huang, Jiao Hu, Xiaoquan Wang, Shunlin Hu, Xiufan Liu · 2023 · Journal of Integrative Agriculture
33. High-complexity extracellular barcoding using a viral hemagglutinin
    Gavriel Mullokandov, Gayathri Vijayakumar, Paul E. Leon, Carole Henry, Patrick C. Wilson, Florian Krammer, Peter Palese, Brian D. Brown · 2020 · Proceedings of the National Academy of Sciences
34. Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies
    Moffat M. Malisheni, Cheng‐Shoong Chong, Tanusya Murali Murali, Kiren Purushotorman, Xinlei Qian, Alfred Laiman, Yee‐Joo Tan, Paul A. MacAry · 2022 · Pathogens
35. Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes
    Philipp Paparoditis, Alexander Fruehwirth, Kajetana Bevc, Jun Siong Low, Josipa Jerak, Laura Terzaghi, Mathilde Foglierini, Blanca Fernandez, David Jarrossay, Davide Corti et al. · 2024 · European Journal of Immunology
36. Single and 2-dose vaccinations with MVA-BN ® induce durable B cell memory responses in healthy volunteers that are comparable to older generation replicating smallpox vaccines
    Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P.H. Meyer, Günter Silbernagl, Rick Nichols, Heinz Weidenthaler, Laurence De Moerlooze et al. · 2022 · medRxiv
37. Mumps Vaccines
    Steven A. Rubin · 2023 · Elsevier eBooks
38. Protective Efficacy of an Inactivated Recombinant Serotype 4 Fowl Adenovirus Against Duck Adenovirus 3 in Muscovy Duck
    Yun Lin, Wenjie Jiang, Lihua Ma, Jiayu Zhang, Ye Tang, Qiuqi Kan, Haifeng Xiong, Jiayan Wu, Jun Zhang, Yiwen Niu et al. · 2024 · Vaccines
39. Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head
    Junxin Li, Min Wang, Yang Yang, Limin Zhang, Lvyan Liu, Wei Zhong Yang, Yun Peng, Xu Zhang, Bin Yuan, Qi Peng et al. · 2025 · Proceedings of the National Academy of Sciences
40. Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse model
    Yu Wang, Xiaozheng He, Jiangyan Zhao, Yunlong Dou, Tingyu Hu, Xia Chen, Xiangrui Ma, Xiaoquan Wang, Shunlin Hu, Jiao Hu et al. · 2025 · Journal of Virology
41. Structural and functional characterization of the antigenicity of influenza A virus hemagglutinin subtype H15
    Disha Bhavsar, André Nicolás León, Wei‐Li Hsu, Eduard Puente‐Massaguer, James A. Ferguson, Julianna Han, Patrick C. Wilson, Andrew B. Ward, Florian Krammer · 2026 · Cell Reports
42. Counteracting Influenza Virus Evolution Through the Full Spectrum of Broadly Protective Antibodies
    Yu Adachi, Yoshimasa Takahashi · 2026 · Immunological Reviews
43. Monoclonal antibodies for diagnostic and therapeutic systems to combat microbial infections
    Parsa Pishva, Irmak C. Kayalan, Fatma Sert, Meral Yüce · 2022 · Elsevier eBooks
44. Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models
    Pureum Lee, Jihee Kim, Hanseul Oh, Chang-Ung Kim, Ahn Young Jeong, Moo‐Seung Lee, Min Seong Jang, Jung Joo Hong, Jung-Eun Park, Doo‐Jin Kim · 2024 · Antiviral Research
45. Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into broad-spectrum inhibitors through receptor blockade
    Payton A. B. Weidenbacher, Eric Waltari, Izumi de los Rios Kobara, Benjamin N. Bell, John E. Pak, Peter S. Kim · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
46. Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
    Arman Izadi, Magdalena Godzwon, Mats Ohlin, Pontus Nordenfelt · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
47. Estudo do efeito adjuvante do peptídeo derivado da proteína NS3 na resposta imunológica de camundongos vacinados com vírus Zika inativado
    Jonathan Ballico de Moraes · 2019
48. The Zika virus NS1 protein as a vaccine target
    Mark J. Bailey, Gene S. Tan · 2021 · Elsevier eBooks
49. Machupo virus with mutations in the transmembrane domain and glycosylation sites is attenuated and immunogenic in animal models of Bolivian Hemorrhagic Fever
    Emily Mantlo, Junki Maruyama, John T Manning, Timothy G. Wanninger, Cheng Huang, Jeanon N. Smith, Michael Patterson, Slobodan Paessler, Takaaki Koma · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
50. Faculty Opinions recommendation of Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
    Nicholas S. Heaton · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
51. Influenza Virus and Vaccination
    Marta L. DeDiego, Aitor Nogales · 2020 · MDPI eBooks
52. Faculty Opinions recommendation of Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.
    Graham Pawelec · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
53. Identification of genetic and antigenic variation and evolution pattern among influenza a and b viruses in Thailand
    Nungruthai Suntronwong · 2020
54. Human cross-protective antibodies to occluded epitopes in influenza hemagglutinin antigen
    Yu Adachi, Keisuke Tonouchi, Yoshimasa Takahashi · 2019 · Uirusu
55. Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza viruses
    Chia-Ying Wu, Yung-Chieh Tseng, Shao-En Kao, Liyang Wu, Jen-Tzu Hou, Yu‐Chih Yang, Pei‐Wen Hsiao, Juine-Ruey Chen · 2023 · Antiviral Research
56. Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids
    Arthur H. van Stigt, Maaike Nederend, Gaby P. Smits, Marjan Kuijer, Rutger M. Schepp, Pieter G. M. van Gageldonk, Anneke H. Hellinga, Rob S. van Binnendijk, Louis Bont, Belinda van’t Land et al. · 2025 · The Journal of Immunology
57. Subtype-specific neutralizing antibodies promote antigenic shift during influenza virus co-infection
    Mengnan Liu, Xiaoran Gao, Xueyang Li, Jinyang Hao, Christine M. Light, Yu Tian, Siqin Wang, Wenyu Yan, Rong Hai, Wei Hu et al. · 2026 · Virulence
58. Structure basis for distinct protective mechanisms of IGHV3-23 antibodies targeting influenza hemagglutinin stem
    Huibin Lv, Yang Wei Huan, Tossapol Pholcharee, Qi Wen Teo, Wenkan Liu, Akshita Baiju Gopal, Danbi Choi, Madison R. Ardagh, Timothy J.C. Tan, Yuanxin Sun et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
59. Additional file 2 of Exploring the global immune landscape of peripheral blood mononuclear cells in H5N6-infected patient with single-cell transcriptomics
    Gao, Jiamin, Wei, Jing, Simei Qin, Liu, Sheng, Shuangyan Mo, Long, Qian, Shiji Tan, Lu, Ning, Xie, Zhouhua, Lin, Jianyan · 2024 · Figshare
60. Additional file 1 of Exploring the global immune landscape of peripheral blood mononuclear cells in H5N6-infected patient with single-cell transcriptomics
    Gao, Jiamin, Wei, Jing, Simei Qin, Liu, Sheng, Shuangyan Mo, Long, Qian, Shiji Tan, Lu, Ning, Xie, Zhouhua, Lin, Jianyan · 2023 · Figshare
61. DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection
    Ane Marie Anderson, Elias Tjärnhage, Daniëla Maria Hinke, Ranveig Braathen, Gunnveig Grødeland, Bjarne Bogen · 2025 · Molecular Therapy — Nucleic Acids
62. Evaluating varicella-zoster virus vaccine immunogenicity through Fc-mediated antibody functions: the roles of ADCP and ADCC
    Sivilay Xayaheuang, Ji‐Young Hwang, Yunhwa Kim, Kyung-Min Lee, Seok-Tae Choi, Eun-Jeong Jang, Ji-Soo Lim, Ji Young Bang, Han Sol Lee, Ok Sarah Shin et al. · 2026 · npj Vaccines
63. Caractérisation des activités antivirales des anticorps anti-VIH-1 et anti-SARS-CoV-2
    Jérémy Dufloo · 2021 · theses.fr (ABES)
64. Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation
    Samantha Mackin, Chieh-Yu Liang, Courtney E. Karl, Maksim Kleverov, Mehak Zahoor Khan, Thendral Selvam, Matthias Mack, Galit Alter, Barbara Guarino, Davide Corti et al. · 2026 · mBio
65. Subclass switching enhances protective efficacy of a non-neutralizing H7N9 avian influenza antibody
    Yunlong Dou, Jiangyan Zhao, Xiaozheng He, Seung-un Song, Erdene-Ochir Tseren-Ochir, Chang‐Seon Song, Xiufan Liu, Jiao Hu, Zenglei Hu · 2026 · Veterinary Microbiology
66. Neutralizing and protective monoclonal antibodies identify antigenic sites in influenza H7 hemagglutinin and select for amino acid substitutions rarely observed at the global level
    Gabriel Ignacio Parra, Marcus Odin, Kentaro Tohma, Falko Schmeisser, Clement A. Meseda, Wei Wang, Carol D. Weiss, Russell A. Vassell, Amy M. Woerner, Cyntia L. Pedro et al. · 2026 · Microbiology Spectrum
67. A bispecific antibody targeting conserved hemagglutinin epitopes confers broad protection against H7 avian influenza and accelerates viral clearance via localized respiratory delivery
    Han Wu, Fan Yang, Ping Wang, Jiamin Fu, Jun Zhang, Jing Guo, 程林芳, Fumin Liu, 吴南屏, Hangping Yao et al. · 2026 · Emerging Microbes & Infections
68. Chronic chikungunya is associated with decreased anti-CHIKV antibody titers, neutralizing capacity, and antibody-dependent cellular cytotoxicity
    Vinit Upasani, Sokchea Lay, Sievleang Heng, Alvino Maestri, Sreymom Ken, Sopheak Sorn, Rithea Leang, Sowath Ly, Veasna Duong, Tineke Cantaert · 2026 · iScience
69. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgR-dependent protection in vivo
    Jeffrey Ravetch · 2024 · ImmPort
70. Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics
    Nadine Rouphael, M Mulligan, Aneesh Mehta, Srilatha Edugupanti, Colleen Kelley, Sarah Kabbani, Allison Beck · 2019 · ImmPort